These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34611647)

  • 1. The impact of mental health conditions on oral anticoagulation therapy and outcomes in patients with atrial fibrillation: A systematic review and meta-analysis.
    Teppo K; Jaakkola J; Lehto M; Biancari F; Airaksinen KEJ
    Am J Prev Cardiol; 2021 Sep; 7():100221. PubMed ID: 34611647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study.
    Jaakkola J; Teppo K; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Linna M; Kinnunen J; Tiili P; Aro AL; Hartikainen J; Airaksinen KEJ; Lehto M
    Eur Heart J Qual Care Clin Outcomes; 2022 May; 8(3):269-276. PubMed ID: 34677571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate doses of non-vitamin K antagonist oral anticoagulants in high-risk subgroups with atrial fibrillation: Systematic review and meta-analysis.
    Kim IS; Kim HJ; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
    J Cardiol; 2018 Oct; 72(4):284-291. PubMed ID: 29706404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
    O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of anticoagulation for atrial fibrillation in patients with cirrhosis: A systematic review and meta-analysis.
    Chokesuwattanaskul R; Thongprayoon C; Bathini T; Torres-Ortiz A; O'Corragain OA; Watthanasuntorn K; Lertjitbanjong P; Sharma K; Prechawat S; Ungprasert P; Kröner PT; Wijarnpreecha K; Cheungpasitporn W
    Dig Liver Dis; 2019 Apr; 51(4):489-495. PubMed ID: 30594462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Gupta S; Um KJ; Pandey A; McIntyre WF; Ivanova M; Allahverdi Y; Agahi P; Pandya F; Lopez A; Sachdeva A; Whitlock RP; Belley-Cote EP
    Cardiovasc Drugs Ther; 2019 Jun; 33(3):339-352. PubMed ID: 31011880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
    Tan J; Liu S; Segal JB; Alexander GC; McAdams-DeMarco M
    BMC Nephrol; 2016 Oct; 17(1):157. PubMed ID: 27769175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation after catheter ablation of atrial fibrillation: An unnecessary evil? A systematic review and meta-analysis.
    Proietti R; AlTurki A; Di Biase L; China P; Forleo G; Corrado A; Marras E; Natale A; Themistoclakis S
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):468-478. PubMed ID: 30575175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation therapy and outcomes in patients with atrial fibrillation and serious mental illness: A systematic review and meta-analysis.
    Farran D; Feely O; Ashworth M; Gaughran F
    J Psychiatr Res; 2022 Dec; 156():737-753. PubMed ID: 36417811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolic risk and effect of oral anticoagulation according to atrial fibrillation patterns: A systematic review and meta-analysis.
    Lilli A; Di Cori A; Zacà V
    Clin Cardiol; 2017 Sep; 40(9):641-647. PubMed ID: 28471498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.
    Durand M; Schnitzer ME; Pang M; Carney G; Eltonsy S; Filion KB; Fisher A; Jun M; Kuo IF; Renoux C; Paterson JM; Quail J; Matteau A;
    CMAJ Open; 2020; 8(4):E877-E886. PubMed ID: 33355273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.
    Clarkesmith DE; Pattison HM; Lane DA
    Cochrane Database Syst Rev; 2013 Jun; (6):CD008600. PubMed ID: 23736948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
    Sterne JA; Bodalia PN; Bryden PA; Davies PA; López-López JA; Okoli GN; Thom HH; Caldwell DM; Dias S; Eaton D; Higgins JP; Hollingworth W; Salisbury C; Savović J; Sofat R; Stephens-Boal A; Welton NJ; Hingorani AD
    Health Technol Assess; 2017 Mar; 21(9):1-386. PubMed ID: 28279251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
    Cullen MW; Kim S; Piccini JP; Ansell JE; Fonarow GC; Hylek EM; Singer DE; Mahaffey KW; Kowey PR; Thomas L; Go AS; Lopes RD; Chang P; Peterson ED; Gersh BJ;
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):461-9. PubMed ID: 23759473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of oral anticoagulation in patients with atrial fibrillation in Portugal: Systematic review and meta-analysis of observational studies.
    Caldeira D; Barra M; David C; Costa J; Ferreira JJ; Pinto FJ
    Rev Port Cardiol; 2014 Sep; 33(9):555-60. PubMed ID: 25240861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mental health conditions and risk of first-ever ischaemic stroke and death in patients with incident atrial fibrillation: A nationwide cohort study.
    Teppo K; Jaakkola J; Biancari F; Halminen O; Putaala J; Mustonen P; Haukka J; Linna M; Kinnunen J; Tiili P; Kouki E; Penttilä T; Hartikainen J; Aro AL; Airaksinen KEJ; Lehto M
    Eur J Clin Invest; 2022 Sep; 52(9):e13801. PubMed ID: 35484936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients.
    Rivera-Caravaca JM; Roldán V; Esteve-Pastor MA; Valdés M; Vicente V; Lip GYH; Marín F
    Thromb Haemost; 2017 Jun; 117(7):1448-1454. PubMed ID: 28331926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.